Linxi Yang

729 citations
17 papers · 564 · 1 hit paper · h-index 6

Impact in

    • RNA modifications and cancer
    • RNA Research and Splicing
    • Circular RNAs in diseases
    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation

Papers in

Linxi Yang

15 papers receiving 556 citations

Linxi Yang's Hit Papers

METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer 2019 · 478 citations
4780+2+4Years since publication100200300400

Peers

Linxi Yang
Comparison fields: 5 of 43
  • Molecular Biology 413
  • Cancer Research 60
  • Gastroenterology 30
  • Oncology 41
  • Pulmonary and Respiratory Medicine 46
Replace Grégoire F. Le Bras with:
Grégoire F. Le Bras United States
Yutaka Hoshino Japan
Xianyu Hu China
Yaozhou He China
Amaury G. Dumont United States
Yasu Jiang China
Hongliang Guo China
Seiji Akiyama Japan
Yue-Xin Ren China
Lin‐Hai Yan China
Linxi Yang relative to Grégoire F. Le Bras United States Grégoire F. Le Bras's profile →
Citations per field
00.5×2×3×4×4.5×
Grégoire F. Le Bras · 1×
Citations per year

Countries citing papers authored by Linxi Yang

Since Specialization
Citations

This map shows the geographic impact of Linxi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linxi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linxi Yang more than expected).

Fields of papers citing papers by Linxi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linxi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linxi Yang. The network helps show where Linxi Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Linxi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Linxi Yang Line = papers co-authored together Linxi Yang links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer
Hit paper breakdown →
2019478
2 201917
3 202214
4 202414
5 201911
6 20247
7 20235
8 20204
9 20214
10 20224
11
Long noncoding RNA SPRY4-IT1 acts as a miR-101-5p sponge to promote gastrointestinal stromal tumor progression by inhibiting ZEB1.
20232
12 20191
13 20201
14 20211
15 20251
16 20190
17 20250

About Linxi Yang

Linxi Yang is a scholar working on Gastroenterology, Cancer Research, Pulmonary and Respiratory Medicine, Biomaterials and Cell Biology, having authored 17 papers that have together received 564 indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (10 papers), Cancer-related molecular mechanisms research (2 papers), RNA Interference and Gene Delivery (1 paper), Heavy Metal Exposure and Toxicity (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Ferroptosis and cancer prognosis (1 paper), Thyroid Cancer Diagnosis and Treatment (1 paper) and Hippo pathway signaling and YAP/TAZ (1 paper). The work is most often cited by research in Molecular Biology (413 citations), Cancer Research (60 citations), Gastroenterology (30 citations), Oncology (41 citations) and Pulmonary and Respiratory Medicine (46 citations). Linxi Yang has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Ben Yue, Zizhen Zhang, Chenlong Song, Ran Cui, Gang Zhao, Bo Ni, Chun Zhuang, Xinli Ma, Hui Cao and Wenyi Zhao. Their work appears in journals such as Molecular Cancer, Diagnostic Pathology, Nature Communications, Journal of Immunology Research and OncoTargets and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact